Annals of neurology

A second major histocompatibility complex susceptibility locus for multiple sclerosis.

Annals of neurology

Yeo TW, De Jager PL, Gregory SG, Barcellos LF, Walton A, Goris A, Fenoglio C, Ban M, Taylor CJ, Goodman RS, Walsh E, Wolfish CS, Horton R, Traherne J, Beck S, Trowsdale J, Caillier SJ, Ivinson AJ, Green T, Pobywajlo S, Lander ES, Pericak-Vance MA, Haines JL, Daly MJ, Oksenberg JR, Hauser SL, Compston A, Hafler DA, Rioux JD, Sawcer S

Marketing and drug costs: who is laughing and crying?

Annals of neurology

Johnston SC, Hauser SL

A status report on neuroscience research, without grade inflation.

Annals of neurology

Johnston SC, Hauser SL

Recombinant therapeutics: from bench to bedside (if your health plan concurs).

Annals of neurology

Hauser SL, Johnston SC

Neurology and medical devices.

Annals of neurology

Johnston SC, Hauser SL

Saving the clinician-scientist: report of the ANA long range planning committee.

Annals of neurology

Hauser SL, McArthur JC

Basic and clinical research: what is the most appropriate weighting in a public investment portfolio?

Annals of neurology

Johnston SC, Hauser SL

How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis.

Annals of neurology

Steinman L, Zamvil SS

Sleepiness in the elderly.

Annals of neurology

Hauser SL

Natalizumab: immune effects and implications for therapy.

Annals of neurology

Hauser SL, Weiner HL

Pages